Solara Active Pharma Sciences Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 417.57 | 383.52 | 392.57 |
| Operating Expense | 344.96 | 319.59 | 329.74 |
| Net Profit | 29.61 | 16.99 | 9.73 |
| Net Profit Margin | 7.09% | 4.43% | 2.48% |
| Earning Per Share | 6.16 | 3.67 | 2.23 |
| EBIDTA | 72.61 | 63.93 | 62.83 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Sep 2026
Revenue417.57
Operating Expense344.96
Net Profit29.61
Net Profit Margin7.09
Earning Per Share6.16
EBIDTA72.61
Effective Tax Rate0
